Literature DB >> 27692776

Association of Rift Valley fever virus infection with miscarriage in Sudanese women: a cross-sectional study.

Maria Baudin1, Ammar M Jumaa2, Huda J E Jomma3, Mubarak S Karsany4, Göran Bucht5, Jonas Näslund5, Clas Ahlm6, Magnus Evander7, Nahla Mohamed1.   

Abstract

BACKGROUND: Rift Valley fever virus is an emerging mosquito-borne virus that causes infections in animals and human beings in Africa and the Arabian Peninsula. Outbreaks of Rift Valley fever lead to mass abortions in livestock, but such abortions have not been identified in human beings. Our aim was to investigate the cause of miscarriages in febrile pregnant women in an area endemic for Rift Valley fever.
METHODS: Pregnant women with fever of unknown origin who attended the governmental hospital of Port Sudan, Sudan, between June 30, 2011, and Nov 17, 2012, were sampled at admission and included in this cross-sectional study. Medical records were retrieved and haematological tests were done on patient samples. Presence of viral RNA as well as antibodies against a variety of viruses were analysed. Any association of viral infections, symptoms, and laboratory parameters to pregnancy outcome was investigated using Pearson's χ2 test.
FINDINGS: Of 130 pregnant women with febrile disease, 28 were infected with Rift Valley fever virus and 31 with chikungunya virus, with typical clinical and laboratory findings for the infection in question. 15 (54%) of 28 women with an acute Rift Valley fever virus infection had miscarriages compared with 12 (12%) of 102 women negative for Rift Valley fever virus (p<0·0001). In a multiple logistic regression analysis, adjusting for age, haemorrhagic disease, and chikungunya virus infection, an acute Rift Valley fever virus infection was an independent predictor of having a miscarriage (odds ratio 7·4, 95% CI 2·7-20·1; p<0·0001).
INTERPRETATION: This study is the first to show an association between infection with Rift Valley fever virus and miscarriage in pregnant women. Further studies are warranted to investigate the possible mechanisms. Our findings have implications for implementation of preventive measures, and evidence-based information to the public in endemic countries should be strongly recommended during Rift Valley fever outbreaks. FUNDING: Schlumberger Faculty for the Future, CRDF Global (31141), the Swedish International Development Cooperation Agency, the County Council of Västerbotten, and the Faculty of Medicine, Umeå University.
Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27692776     DOI: 10.1016/S2214-109X(16)30176-0

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  51 in total

1.  Introduction to Environmental Harmful Factors.

Authors:  Jiarong Guo; Peng Tian; Zhongyan Xu; Huidong Zhang
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition.

Authors:  Nathaniel S Chapman; Haiyan Zhao; Nurgun Kose; Jonna B Westover; Birte Kalveram; Robin Bombardi; Jessica Rodriguez; Rachel Sutton; Joseph Genualdi; A Desiree LaBeaud; Francis M Mutuku; Phillip R Pittman; Alexander N Freiberg; Brian B Gowen; Daved H Fremont; James E Crowe
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-06       Impact factor: 11.205

3.  Seroprevalence of Rift Valley Fever and West Nile Fever in Cattle in Gambella Region, South West Ethiopia.

Authors:  Getahun Asebe; Gezahegne Mamo; Daniela Michlmayr; Woldaregay Erku Abegaz; Adugna Endale; Girmay Medhin; James W Larrick; Mengistu Legesse
Journal:  Vet Med (Auckl)       Date:  2020-11-19

4.  Viral and Bacterial Zoonotic Agents in Dromedary Camels from Southern Tunisia: A Seroprevalence Study.

Authors:  Simone Eckstein; Rosina Ehmann; Abderraouf Gritli; Mohamed Ben Rhaiem; Houcine Ben Yahia; Manuel Diehl; Roman Wölfel; Susann Handrick; Mohamed Ben Moussa; Kilian Stoecker
Journal:  Microorganisms       Date:  2022-03-29

5.  Rift Valley fever virus detection in susceptible hosts with special emphasis in insects.

Authors:  K M Gregor; L M Michaely; B Gutjahr; M Rissmann; M Keller; S Dornbusch; F Naccache; K Schön; S Jansen; A Heitmann; R König; B Brennan; R M Elliott; S Becker; M Eiden; I Spitzbarth; W Baumgärtner; C Puff; R Ulrich; M H Groschup
Journal:  Sci Rep       Date:  2021-05-10       Impact factor: 4.379

Review 6.  Rift Valley fever: biology and epidemiology.

Authors:  Daniel Wright; Jeroen Kortekaas; Thomas A Bowden; George M Warimwe
Journal:  J Gen Virol       Date:  2019-07-16       Impact factor: 5.141

Review 7.  Plant-made vaccines and reagents for the One Health initiative.

Authors:  Edward Peter Rybicki
Journal:  Hum Vaccin Immunother       Date:  2017-08-28       Impact factor: 3.452

Review 8.  Urban Chikungunya in the Middle East and North Africa: A systematic review.

Authors:  John M Humphrey; Natalie B Cleton; Chantal B E M Reusken; Marshall J Glesby; Marion P G Koopmans; Laith J Abu-Raddad
Journal:  PLoS Negl Trop Dis       Date:  2017-06-26

Review 9.  Mosquito-Associated Viruses and Their Related Mosquitoes in West Africa.

Authors:  Eric Agboli; Julien B Z Zahouli; Athanase Badolo; Hanna Jöst
Journal:  Viruses       Date:  2021-05-12       Impact factor: 5.048

10.  Anti-Rift Valley fever virus activity in vitro, pre-clinical pharmacokinetics and oral bioavailability of benzavir-2, a broad-acting antiviral compound.

Authors:  Md Koushikul Islam; Mårten Strand; Michael Saleeb; Richard Svensson; Pawel Baranczewski; Per Artursson; Göran Wadell; Clas Ahlm; Mikael Elofsson; Magnus Evander
Journal:  Sci Rep       Date:  2018-01-31       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.